N@N

Carter Gould Maintained (AMGN) at Sell with Increased Target to $240 on, Jan 18th, 2023

Carter Gould of Barclays, Maintained "Amgen Inc." (AMGN) at Sell with Increased Target from $234 to $240 on, Jan 18th, 2023.

Carter has made no other calls on AMGN in the last 4 months.

There are 7 other peers that have a rating on AMGN. Out of the 7 peers that are also analyzing AMGN, 3 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $285 on, Tuesday, January 3rd, 2023
• David Risinger of "SVB Leerink" Maintained at Hold with Increased Target to $282 on, Thursday, December 22nd, 2022
• Gregory Renza of "RBC Capital" Maintained at Hold with Increased Target to $240 on, Friday, November 4th, 2022

These are the ratings of the 4 analyists that currently disagree with Carter

---

• Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $299 on, Tuesday, December 13th, 2022
• Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $310 on, Tuesday, December 6th, 2022
• Trung Huynh of "Credit Suisse" Initiated at Sell and Held Target at $240 on, Friday, November 18th, 2022
• Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $282 on, Friday, November 4th, 2022

Contributing Sources

---